This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
Nutrition Journal Open Access 07 June 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheridan, C. Pivotal trials for β-secretase inhibitors in Alzheimer's. Nat Biotechnol 33, 115–116 (2015). https://doi.org/10.1038/nbt0215-115
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0215-115
This article is cited by
-
Everything but amyloid: new thinking prompts FDA revamp
Nature Biotechnology (2018)
-
Hope for anti-amyloid antibodies surges, yet again
Nature Biotechnology (2016)
-
Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
Nutrition Journal (2015)